Cargando…

Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial

IMPORTANCE: Proactive treatment of nonproliferative diabetic retinopathy (NPDR) reduces the risk of progression to vision-threatening complications. OBJECTIVE: To evaluate vascular endothelial growth factor blockade therapy with intravitreal aflibercept injections in eyes with severe NPDR without di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brown, David M., Wykoff, Charles C., Boyer, David, Heier, Jeffrey S., Clark, W. Lloyd, Emanuelli, Andres, Higgins, Patrick M., Singer, Michael, Weinreich, David M., Yancopoulos, George D., Berliner, Alyson J., Chu, Karen, Reed, Kimberly, Cheng, Yenchieh, Vitti, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343518/ https://www.ncbi.nlm.nih.gov/pubmed/34351414 http://dx.doi.org/10.1001/jamaophthalmol.2021.2809

Ejemplares similares

INTRAVITREAL NESVACUMAB (ANTIANGIOPOIETIN 2) PLUS AFLIBERCEPT IN DIABETIC MACULAR EDEMA: Phase 2 RUBY Randomized Trial
por: Brown, David M., et al.
Publicado: (2022)

Intravitreal Nesvacumab (Anti-Angiopoietin-2) Plus Aflibercept in Neovascular AMD: Phase 2 ONYX Randomized Trial
por: Heier, Jeffrey S., et al.
Publicado: (2022)

EFFICACY AND SAFETY OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOCUSING ON PATIENTS WITH DIABETIC MACULAR EDEMA FROM JAPAN
por: Terasaki, Hiroko, et al.
Publicado: (2019)

Intravitreal aflibercept injection in Indian eyes with retinopathy of prematurity
por: Vedantham, Vasumathy
Publicado: (2019)

Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept Injection
por: Suren, Elcin, et al.
Publicado: (2020)

Erratum: Intravitreal aflibercept injection in Indian eyes with retinopathy of prematurity
Publicado: (2019)

Ocular Rigidity and Outflow Facility in Nonproliferative Diabetic Retinopathy
por: Panagiotoglou, Theonitsa, et al.
Publicado: (2015)

Endophthalmitis Caused by Agrobacterium radiobacter following Intravitreal Aflibercept for Diabetic Retinopathy
por: Rohowetz, Landon J., et al.
Publicado: (2020)

Determining Risk Factors That Affect Progression in Patients with Nonproliferative Diabetic Retinopathy
por: Chen, Dalbert J., et al.
Publicado: (2021)

Associations between Macular OCT Angiography and Nonproliferative Diabetic Retinopathy in Young Patients with Type 1 Diabetes Mellitus
por: Veiby, Nina C. B. B., et al.
Publicado: (2020)

Randomized Trial of Treat-and-Extend Intravitreal Aflibercept for Radiation Retinopathy: 1-Year Outcomes
por: Trejo Corona, Stephanie, et al.
Publicado: (2023)

Serum TNF-Alpha Level Predicts Nonproliferative Diabetic Retinopathy in Children
por: Zorena, Katarzyna, et al.
Publicado: (2007)

Intervention with vitamins in patients with nonproliferative diabetic retinopathy: a pilot study
por: Smolek, Michael K, et al.
Publicado: (2013)

Optical Coherence Tomography Angiography Contributions in Classification of Nonproliferative Diabetic Retinopathy
por: Kasumovic, Armin, et al.
Publicado: (2020)

Infographic: intravitreous aflibercept vs vitrectomy with panretinal photocoagulation for vitreous haemorrhage from proliferative diabetic retinopathy
por: Song, Anna, et al.
Publicado: (2021)

Effects of Intravitreal Aflibercept on Retinal Function and Improvement of Macular Edema Associated With Diabetic Retinopathy
por: Ichio, Atsushi, et al.
Publicado: (2020)

Decreased Retinal Thickness in Type 1 Diabetic Children with Signs of Nonproliferative Diabetic Retinopathy
por: Ruiz-Ocaña, P., et al.
Publicado: (2018)

Update on the Management of Diabetic Retinopathy: Anti-VEGF Agents for the Prevention of Complications and Progression of Nonproliferative and Proliferative Retinopathy
por: Bahr, Tyler A., et al.
Publicado: (2023)

The 2-Year Leakage Index and Quantitative Microaneurysm Results of the RECOVERY Study: Quantitative Ultra-Widefield Findings in Proliferative Diabetic Retinopathy Treated with Intravitreal Aflibercept
por: Babiuch, Amy S., et al.
Publicado: (2021)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
por: Fouda, Sameh Mosaad, et al.
Publicado: (2017)

Elevated Levels of Plasma IgA Autoantibodies against Oxidized LDL Found in Proliferative Diabetic Retinopathy but Not in Nonproliferative Retinopathy
por: Vavuli, Satu, et al.
Publicado: (2016)

Intravitreal aflibercept partially reverses severe non-proliferative diabetic retinopathy in treatment-naïve patients
por: Tao, Yuan, et al.
Publicado: (2021)

Intravitreal ziv-aflibercept in diabetic vitreous hemorrhage
por: Mansour, Ahmad M., et al.
Publicado: (2020)

Systemic pharmacokinetic/pharmacodynamic analysis of intravitreal aflibercept injection in patients with retinal diseases
por: Kaiser, Peter K, et al.
Publicado: (2019)

Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
por: Jung, Byung Ju, et al.
Publicado: (2019)

Assessment of optical coherence tomography angiography and multifocal electroretinography in eyes with and without nonproliferative diabetic retinopathy
por: Srinivasan, Sangeetha, et al.
Publicado: (2021)

Prospective, Single-Center, Six-Month Study of Intravitreal Ranibizumab for Macular Edema with Nonproliferative Diabetic Retinopathy: Effects on Microaneurysm Turnover and Non-Perfused Retinal Area
por: Lee, Seung Joon, et al.
Publicado: (2020)

Intravitreal Ranibizumab Alone or in Combination with Calcium Dobesilate for the Treatment of Diabetic Macular Edema in Nonproliferative Diabetic Retinopathy Patients: 12-Month Outcomes of a Retrospective Study
por: Wang, Dongxuan, et al.
Publicado: (2022)

Therapeutic Effect of Abelmoschus manihot on Type 2 Diabetic Nonproliferative Retinopathy and the Involvement of VEGF
por: Zhao, Yue, et al.
Publicado: (2020)

Different Risk Profiles for Progression of Nonproliferative Diabetic Retinopathy: A 2-Year Study
por: Marques, Inês P., et al.
Publicado: (2022)

Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema
por: Tatsumi, Tomoaki, et al.
Publicado: (2022)

Efficacy of intravitreal AFlibercept injection For Improvement of retinal Nonperfusion In diabeTic retinopathY (AFFINITY study)
por: Kim, Yoon Jeon, et al.
Publicado: (2020)

Using Ultrawide Field-Directed Optical Coherence Tomography for Differentiating Nonproliferative and Proliferative Diabetic Retinopathy
por: Ashraf, Mohamed, et al.
Publicado: (2023)

The underestimated significance of nonproliferative lupus nephritis
por: Kwok, Seung-Ki
Publicado: (2023)

Brentuximab vedotin related bilateral Purtscher-like retinopathy unresponsive to pulse steroid therapy and intravitreal aflibercept injection
por: Ayhan, Ziya, et al.
Publicado: (2017)

Clinical Comparative Study of Intravitreal Injection of Triamcinolone Acetonide and Aflibercept in the Treatment of Diabetic Retinopathy Cystoid Macular Edema
por: Zhu, Yanxia, et al.
Publicado: (2022)

Comparison of Clinical Outcomes of Intravitreal Bevacizumab and Aflibercept in Type 1 Prethreshold Retinopathy of Prematurity in Posterior Zone II
por: Eftekhari Milani, Amir, et al.
Publicado: (2022)

Prophylactic intravitreal injection of aflibercept for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy: A randomized controlled trial
por: Qu, Jinfeng, et al.
Publicado: (2023)

Superficial capillary perfusion on optical coherence tomography angiography differentiates moderate and severe nonproliferative diabetic retinopathy
por: Ong, Janice X., et al.
Publicado: (2020)

SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB
por: Avery, Robert L., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4240c7mua0ci8fupnad0rj18eq